Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Egyptian Journal of Hospital Medicine [The]. 2017; 69 (8): 2981-2985
in English | IMEMR | ID: emr-190080

ABSTRACT

Background: the co-administration of ketamine and propofol [CoKP] is thought to maximize the beneficial profile of each medication, while minimizing the respective adverse effects of each medication


Objective: our objective was to compare adverse events between ketamine monotherapy [KM] and CoKP for procedural sedation and analgesia [PSA] in a pediatric emergency department [ED]


Methods: this was a prospective, randomized, single-blinded, controlled trial of KM vs. CoKP in patients between 3 and 21 years of age. The attending physician administered either ketamine 1 mg/kg i.v. or ketamine 0.5 mg/kg and propofol 0.5 mg/kg i.v. The physician could administer up to three additional doses of ketamine [0.5 mg/kg/dose] or ketamine/propofol [0.25 mg/kg/dose of each]. Adverse events [e.g., respiratory events, cardiovascular events, unpleasant emergence reactions] were recorded. Secondary outcomes included efficacy, recovery time, and satisfaction scores


Results: thirty-two patients were randomized to KM and 29 patients were randomized to CoKP. There was no difference in adverse events or type of adverse event, except nausea was more common in the KM group. Efficacy of PSA was higher in the KM group [99%] compared to the CoKP group [90%]. Median recovery time was the same


Conclusions: we found no significant differences in adverse events between the KM and CoKP groups. While CoKP is a reasonable choice for pediatric PSA, our study did not demonstrate an advantage of this combination over KM

2.
Egyptian Journal of Hospital Medicine [The]. 2017; 69 (6): 2680-2684
in English | IMEMR | ID: emr-190682

ABSTRACT

Elderly individuals are very vulnerable to influenza infection, and more prone to influenza-related morbidity and mortality. However, the prevalence of elderly persons receiving influenza vaccine remains low. Many factors have been proposed as the cause beyond this low prevalence, with knowledge and misconceptions about the vaccine on the top of the list


Objectives: the aim of this review is to assess the knowledge, attitude, and prevalence of flu vaccine and its effect among elderly


Methods: To achieve this aim, online database search was conducted to review articles stating knowledge, attitude, and incidence of flu vaccine and its effects among elderly. PubMed was searched for appropriately-related studies that address the studied parameters. PubMed search yielded 19 results, we quickly inspected the abstracts of these results to select those with most relevant data. Of 19 articles, 8 were chosen for review


Results: The prevalence of influenza vaccine ranged from 58% to 73%. Inadequate or lack of knowledge about the vaccine were common in over half of the elderly patients not receiving vaccine. The vast majority [>90%] of those received the vaccine did so after a clear recommendation by their physicians


Discussion: Inadequate knowledge and false beliefs about the influenza vaccines were the main cause of low vaccination rate among elderly. Physicians advice and health education were the most potent influencer on raising the prevalence of elderly immunization

SELECTION OF CITATIONS
SEARCH DETAIL